JHLT: The Podcast – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

JHLT: The Podcast

ISHLT

Sciences

Fréquence : 1 épisode/23j. Total Éps: 91

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.

Site

RSS

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

Aucun classement récent disponible

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://www.jhltonline.org/article/S1053-2498
136 partages
http://www.jhltonline.org/current
85 partages
https://www.jhltonline.org/
82 partages

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 62%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

Episode 72: Impact of Donor-Specific Antibodies on Longitudinal Lung Function and BLAD

Saison 5 · Épisode 17

mercredi 5 novembre 2025 • Durée 19:54

On this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on the paper, "Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction."

They are joined by the first author, Muhtadi Alnababteh, MD, Assistant Professor at the University of Maryland and Staff Clinician at the National Institutes of Health, and senior author Michael Keller, MD, of the Pulmonary and Critical Care division at the University of Maryland.

The discussion explores:

Common characteristics of patients who developed donor-specific antibodies (DSA)
Differences in outcomes depending on when DSA developed
Associations between the development of DSA and antibody-mediated rejection, and related time frames

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Lire plusRéduire

Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days

Saison 5 · Épisode 16

mercredi 15 octobre 2025 • Durée 21:09

On this episode of JHLT: The Podcast, the Digital Media Editors invite co-lead author Nir Uriel, MD, Director of Advanced Heart Failure and Cardiac Transplantation at New York Presbyterian Hospital and Professor of Medicine at Columbia University.

Dr. Uriel joins to discuss the work of the Cardiogenic Shock Working Group (CSWG) and their recent paper, "Outcomes of patients supported on Impella 5.5 for more than 14 days: A Cardiogenic Shock Working Group registry analysis."

The discussion explores:

Why patients on longer duration of MCS had better survival but maintained similar rates of serious adverse events (SAEs)
Why the study might show fewer SAEs than the literature historically shows
How temporary MCS devices are selected in clinical settings in patients with cardiogenic shock
The ongoing and upcoming activities of CSWG

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Lire plusRéduire

Episode 62: Apixaban Plasma Levels in Patients with HeartMate 3

Saison 5 · Épisode 7

jeudi 10 avril 2025 • Durée 12:40

Returning for a second study this month, the JHLT Digital Media Editors invite first author Charlotte Van Edom to discuss the paper, "Apixaban plasma levels in patients with HeartMate 3 support."

As a cardiologist in training and a PhD candidate at the University Hospitals Leuven in Belgium, Van Edom's work focuses on hemocompatibility and mechanical circulatory support, covering both short-term and long-term support.

The episode explores:

The evolution of the use and understanding of direct oral anticoagulants (DOACs) during LVAD support, including the increased focus on Factor Xa inhibitors
Encouraging findings from the study and what clinical practices might need to change if introducing apixaban
Additional studies exploring DOACs in LVAD patients

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Treat or research pulmonary vascular diseases? Check out the first April episode for a study on sotatercept in PAH patients.

Lire plusRéduire

Episode 61: Is Sotatercept safe in patients with PAH?

Saison 5 · Épisode 6

mercredi 2 avril 2025 • Durée 13:00

On this episode of JHLT: The Podcast, the Digital Media Editors invite author Ioana Preston, MD, to discuss the paper, "Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR."

Dr. Preston is the director of the pulmonary hypertension center at Lahey Hospital and Medical Center in Burlington, Massachusetts, and has over 20 years of experience in caring for patients with PH, as well as multiple clinical trials in PH.

The episode explores:

What makes sotatercept unique as the first "biologic" in the treatment of PAH
Hypotheses about the mechanism of action in sotatercept
Sotatercept's interaction with mPAP and what it indicates about the drug's action on the pulmonary vasculature

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those involved in the heart failure and mechanical circulatory support should tune in again later this month for a study on apixaban plasma levels in patients with HeartMate 3 support.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at .

Episode 60: Riociguat in patients with PAH and Cardiometabolic Comorbidities

Saison 5 · Épisode 6

mardi 18 mars 2025 • Durée 07:19

Returning for a second study this month, the JHLT Digital Media Editors conduct an internal discussion on the paper, "Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials."

The episode explores:

The aging PAH population and the new comorbidities that must be considered in research
How the study augments and expands on recent standards, like the 2022 ESC/ERS guidelines for pulmonary hypertension
Limitations on the study and opportunities for future research

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on lung transplant teams should check the previous episode for a study on how rewarming ischemia time affects lung transplant outcomes.

Lire plusRéduire

Episode 59: Rewarming Ischemia Time in Lung Transplantation

Saison 5 · Épisode 5

mercredi 5 mars 2025 • Durée 13:36

On this episode of JHLT: The Podcast, the Digital Media Editors invite lead author Jan Van Slambrouck, MD, to discuss the paper, "The effect of rewarming ischemia on tissue transcriptome and metabolome signatures: A clinical observational study in lung transplantation."

Dr. Van Slambrouck is a general surgeon who's just finished his PhD training at the KU Leuven lab of respiratory disease and thoracic surgery in Belgium.

The episode explores:

How rewarming ischemia time (RIT) affects donor lungs, especially on the molecular level
The pace of rewarming and how prior literature prepared the team to track and evaluate it
Clinical strategies to reduce RIT and directly address molecular changes

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those involved in the pulmonary vascular disease space should tune in again later this month for a study on the safety and efficacy of riociguat in patients with PAH.

Episode 58: Sympathetic Reinnervation

Saison 5 · Épisode 4

jeudi 20 février 2025 • Durée 12:45

Returning for a second study this month, the JHLT Digital Media Editors invite lead author Oliver J.F. Weiner, to discuss the paper, "Sympathetic reinnervation in cardiac transplant recipients: Prevalence, time course, and association with long-term survival."

Dr. Weiner is currently an out of training registrar at Monash Health in Melbourne, Australia, but will soon return to his home of the UK to begin internal medicine training with the intention becoming a cardiologist. He is especially interested in advanced heart failure and electrophysiology.

The episode explores:

The uncertainty around clinical influences on reinnervation
The importance of this single-center study in expanding the literature
Potential future treatment options

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on lung transplant teams should check the previous episode for a study on recent trends and post-transplant outcomes from EVLP.

Lire plusRéduire

Episode 57: Trends and Outcomes in EVLP

Saison 5 · Épisode 3

mercredi 5 février 2025 • Durée 12:22

On this episode of JHLT: The Podcast, the Digital Media Editors invite lead author Jonathan E. Williams, MD, to discuss the paper, "Ex-Vivo Lung Perfusion: National Trends and Post-Transplant Outcomes."

Dr. Williams is a general surgery resident at the University of Michigan in Ann Arbor, with work focusing on contemporary lung preservation strategies, perfusion techniques, and particularly, EVLP.

The episode explores:

How the study explores the theory that EVLP use may increase transplant volumes
Preserving data quality and other study limitations
How to work in fields of study that sometimes yield as many questions as answers

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on heart transplant teams should tune in again later this month for a study on sympathetic reinnervation in cardiac transplant recipients.

Lire plusRéduire

Episode 56: The Best Studies of 2024

Saison 5 · Épisode 2

jeudi 16 janvier 2025 • Durée 11:51

JHLT: The Podcast returns with a year-end recap of 2024. Each Digital Media Editor shares one of their favorite studies from JHLT in 2024 for a quick recap of last year's excellent science in advanced heart and lung disease.

Studies featured:

· Cardiac magnetic resonance assessment of acute rejection and cardiac allograft vasculopathy in pediatric heart transplant
Kikano, Sandra et al. JHLT May 2024 5(43):745-754

· A modular simulation framework for organ allocation
Rose, Johnie et al. JHLT Aug 2024 8(43):1326-1335.

· HeartMate 3 Snoopy: Noninvasive cardiovascular diagnosis of patients with fully magnetically levitated blood pumps during echocardiographic speed ramp tests and Valsalva maneuvers
Schlöglhofer, Thomas et al. JHLT Feb 2024 2(43):251-260.

· Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group
Kochar, Ajar et al. JHLT Nov 2024 11(43):1846-1856.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at for a free subscription, or subscribe today at .

Episode 55: Meet the Editors!

Saison 5 · Épisode 1

mercredi 8 janvier 2025 • Durée 16:21

Happy new year from JHLT: The Podcast! On this episode, the Digital Media Editors are joined by ISHLT Director of Marketing + Communications Jess Burke, CAE, to share a little bit about themselves and their backgrounds.

Hear about how each of the JHLT Digital Media Editors got involved in transplantation and a little about each of their research and personal interests.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Lire plusRéduire

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à JHLT: The Podcast. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

À propos Méthodologie Contact Me soutenir Politique de confidentialité

JHLT: The Podcast – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other57

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Podcasts Similaires Basées sur le Contenu

Other57